Antihyperalgesic effects of ProTx-II, a Nav1.7 antagonist, and A803467, a Nav1.8 antagonist, in diabetic mice
Ken-ichiro Tanaka,1,2, Shota Sekino,1 Megumi Ikegami,1 Hiroko Ikeda,1 Junzo Kamei11Department of Pathophysiology and Therapeutics, School of Pharmacy and Pharmaceutical Sciences, Hoshi University, Tokyo, Japan; 2Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City U...
Saved in:
Main Authors: | Tanaka KI (Author), Sekino S (Author), Ikegami M (Author), Ikeda H (Author), Kamei J (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The road to evolution of ProTx2: how to be a subtype-specific inhibition of human Nav1.7
by: Fan Zhao, et al.
Published: (2024) -
Left-shifted Nav channels in injured bilayer: primary targets for neuroprotective Nav antagonists?
by: Catherine E Morris, et al.
Published: (2012) -
Carvacrol inhibits the neuronal voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.3, Nav1.7, and Nav1.8 expressed in Xenopus oocytes with different potencies
by: Takafumi Horishita, et al.
Published: (2020) -
Acidosis differentially modulates inactivation in NaV1.2, NaV1.4, and NaV1.5 channels
by: Yury Y. Vilin, et al.
Published: (2012) -
Physiological and pathophysiological insights of Nav1.4 and Nav1.5 comparison
by: Gildas eLoussouarn, et al.
Published: (2016)